Modeling Transitions between Responsive and Resistant States in Breast Cancer with Application to Therapy Optimization
Abstract
We present a mathematical model that captures the transitions among three experimentally observed estrogen-sensitivity phenotypes in breast cancer cells. Based on this model, a population-level model is created and used to explore the optimization of a therapeutic protocol
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling Breast Cancer Proliferation, Drug Synergies, and Alternating Therapies
Wei He, Diane M. Demas, … William T. Baumann·iSciencePeer-reviewed·Apr 23, 2023
- A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
Grant R. Howard, Kaitlyn E. Johnson, … Amy Brock·Scientific ReportsPeer-reviewed·Aug 7, 2018
- A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies
X. Li, D. Thirumalai·bioRxiv·Jun 4, 2021
- A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells
S. Sahoo, A. Mishra, … M. K. Jolly·bioRxiv·Mar 14, 2021
- Impacts of competition and phenotypic plasticity on the viability of adaptive therapy
B. Vibishan, Paras Jain, … Mohit Kumar Jolly·Mathematical BiosciencesPeer-reviewed·Nov 1, 2025
- Modelling bistable tumour population dynamics to design effective treatment strategies
A. R. Akhmetzhanov, J. W. Kim, … C.-H. Yeang·bioRxiv·Apr 8, 2019